Company overview
Nicoya Lifesciences provides integrated biophysical characterization instruments for biopharma R&D, including Surface Plasmon Resonance (SPR) for label-free interaction analysis, Circular Dichroism (CD) for protein structure, stopped-flow kinetics, and differential scanning fluorimetry (DSF) for stability assessment. Following its 2025 acquisition of Applied Photophysics, Nicoya offers a unified platform combining these technologies to support drug discovery, optimization, and quality control workflows. Their benchtop systems like Alto, Revo, and Chirascan enable high-throughput, reproducible data for biologics developability and mechanism of action studies.
Nicoya Lifesciences Inc. is listed in the NovaPharmaNews Supplier Hub as a Life Science Reagents, Lab Equipment & Instruments partner serving United States & Americas. Core focus areas include nicoya lifesciences, biologics characterization, surface plasmon resonance, spr instruments, protein stability tools.
Industry categories: Life Science Reagents, Lab Equipment & Instruments. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://nicoyalife.com
- Categories
- Life Science Reagents, Lab Equipment & Instruments
- Markets served
- United States & Americas
- Keywords
- nicoya lifesciences, biologics characterization, surface plasmon resonance, spr instruments, protein stability tools
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What biophysical characterization technologies does Nicoya offer?
- Nicoya provides Surface Plasmon Resonance (SPR) via Alto and Revo for kinetics and binding, Circular Dichroism (Chirascan) for protein structure, stopped-flow (SX) for rapid kinetics, and DSF (SUPR-DSF) for stability, integrated post-Applied Photophysics acquisition.
- Which stages of drug development do Nicoya's solutions support?
- Solutions cover discovery screening, candidate optimization, mechanism of action studies, characterization, and quality control for biologics, delivering insights into function, structure, and stability.
- What are the key benefits for pharma and biotech labs?
- Nicoya's benchtop instruments offer high-throughput, publication-quality data at reduced cost and complexity, suitable for academic, biotech, CRO, and pharma teams, with AI/ML-compatible multi-parameter datasets.
Related editorial coverage
- $2M Gene Therapy Cures Need a Financing Model
- A Secure And Intelligent Drug Delivery Model Integrating Neural Networks With Blockchain
- AACR 2024: Daily Oncology Research Roundup
- AACR 2024: Oncology News & Key Takeaways - Day 1
- AACR 2024: Oncology Research Highlights - Day 1 Roundup
- AACR 2026: AI Pathology & Oncolytic Virus Spark Interest
Explore lab tools and QA/QC resources for R&D teams.
